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Abstract. 
 
We previously hypothesized that the type I 
keratin 16 (K16) plays a role in the process of kerati-
nocyte activation that occurs in response to skin injury 
(Paladini, R.D., K. Takahashi, N.S. Bravo, and P.A. 
 
Coulombe. 1996.
 
 J. Cell Biol.
 
 132:381–397). To further 
examine its properties in vivo, the human K16 cDNA 
was constitutively expressed in the progenitor basal 
layer of transgenic mouse skin using the K14 gene pro-
moter. Mice that express approximately as much K16 
protein as endogenous K14 display a dramatic postna-
tal phenotype that consists of skin that is hyperkera-
totic, scaly, and essentially devoid of fur. Histologically, 
the epidermis is thickened because of hyperprolifera-
tion of transgenic basal cells, whereas the hair follicles 
are decreased in number, poorly developed, and hypo-
proliferative. Microscopically, the transgenic kerati-
nocytes are hypertrophic and feature an altered keratin 
filament network and decreased cell–cell adhesion. The 
 
phenotype normalizes at 
 
z
 
5 wk after birth. In contrast, 
control mice expressing a K16-K14 chimeric protein to 
comparable levels are normal. The character and tem-
poral evolution of the phenotype in the K16 transgenic 
mice are reminiscent of the activated EGF receptor–
mediated signaling pathway in skin. In fact, tyrosine 
phosphorylation of the EGF receptor is increased in 
the newborn skin of K16 transgenic mice. We conclude 
that expression of K16 can significantly alter the re-
sponse of skin keratinocytes to signaling cues, a distinc-
tive property likely resulting from its unique COOH-
terminal tail domain.
Key words: skin • keratin • adhesion • wound repair 
• transgenic mouse
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 thickness injury to the epidermis, a stratified
squamous epithelium, induces dramatic morpho-
logical changes in suprabasal keratinocytes located
at the edges of the wound. Before beginning migration
into the wound site at 16–24 h after injury in the form of a
stratified epithelial sheet (3, 12), suprabasal cells at the
wound edge undergo a process termed keratinocyte acti-
vation (14). During this activation phase, changes in gene
expression contribute to major morphological alterations
in the cytoarchitecture of the keratinocytes. These include
cellular hypertrophy, the fragmentation of keratin fila-
ments and their relocation adjacent to the nucleus, and
changes in the number and structure of desmosomes that
correlate with an increase in space between keratinocytes
(12, 69). As a result, the process of terminal differentiation
in these cells is perturbed.
One of the hallmarks of the epidermis is the pro-
grammed expression of keratin genes that is determined
by the location and function of the keratinocyte within the
epidermis (21). Basal cells, which are the progenitor, di-
viding cells of the epidermis, express keratin K5 (type II),
keratin K14 (type I) (66), and low amounts of keratin K15
(type I) (48). By exiting the cell cycle and migrating up-
ward, basal cells begin the terminal differentiation process
that results in the production of squames. A distinctive
molecular change concomitant with the onset of differenti-
ation is the switch from the expression of K5 and K14 to
the expression of the type II keratin K1 and the type I ker-
atin K10 (22). A structural function for keratins in the epi-
dermis has been clearly defined by several transgenic
mouse studies in which either the introduction of domi-
nant-negative mutant proteins (17, 23, 70, 73, 87) or the
absence of the protein (48) resulted in an epidermis that
was susceptible to blistering. The location of the blistering
within the epidermis is determined by where the genetic
alteration has occurred. Mutations in the keratin genes for
K1, K5, K2e, K9, K10, and K14 have been found to cause
several human genodermatoses such as epidermolysis
bullosa simplex, epidermolytic hyperkeratosis, and pal-
moplantar keratoderma (15, 39, 56).
The type II keratin K6 and the type I keratins K16 and
K17 are constitutively expressed at low levels in a number
 
Address all correspondence to Pierre A. Coulombe, Ph.D., Dept. of Bio-
logical Chemistry, Johns Hopkins University School of Medicine, 725 N.
Wolfe Street, Baltimore, MD 21205. Tel.: (410) 614-0510. Fax: (410) 955-
5759. E-mail: coulombe@jhu.edu
  
The Journal of Cell Biology, Volume 142, 1998 1036
 
of stratified epithelium including palmar and plantar epi-
dermis, tongue, oral mucosa, and the outer root sheath of
the hair follicle (55, 60, 68). These keratins are not present
in normal interfollicular epidermis but their expression is
rapidly induced in suprabasal cells located at the edges of
wounds. In addition to this induction, K6, K16, and K17
are also expressed in stratified epithelia featuring hyper-
proliferation or abnormal differentiation, including psoria-
sis and cancer (55, 79, 90). Keratinocytes from these ab-
normal conditions feature some of the cytoarchitectural
changes that are observed in wound edge keratinocytes in-
cluding hypertrophy, filament abnormalities, and reduc-
tions in cell–cell adhesion (82). These data suggest a rela-
tionship between the expression of these keratins and
differences in keratinocyte differentiation and cytoarchi-
tecture.
A remarkable feature of K6, K16, and K17 is the high
degree of sequence identity that they share with their
basal keratin counterparts (K5 and K14). For example,
along the tripartite head–rod–tail domain structure of ker-
atins, K16 and K14 are 91%–86%–38% identical in their
primary sequence (55, 85). The question arises as to why a
keratinocyte under certain conditions would synthesize
two new keratins that are very similar to the keratins that
are already present. One simple possibility is that the func-
tion that these keratins are performing is not strictly struc-
tural. There is ample evidence that this may be true for
keratin 16.
For example, a dominant-negative mutation in K16 that
has been reported in a case of Jadassohn-Lewandowsky
Pachyonychia Congenita results in filament aggregation
near the nucleus and a decrease in the number of desmo-
somes (57). However, cytolysis does not occur in these ke-
ratinocytes, which is in stark contrast to the fact that com-
parable mutations in the other epidermal keratins (K1,
K2e, K5, K9, K10, and K14) do result in cytolysis (15, 56).
In addition, the tissue-specific overexpression of wild-type
human K16 in transgenic mouse epidermis resulted in ab-
errant keratinization and hyperproliferation (82). These
changes were also accompanied by keratin filament reor-
ganization and a decrease in desmosomes at the cell sur-
face. Finally, biochemical and cell culture experiments re-
vealed that K16, unlike K5, K6, and K14 promoted the
formation of short filaments that preferentially localized
near the nucleus of cells (69). These data have led to the
hypothesis that K16 may play a role in promoting many of
the cytoarchitectural changes that occur in suprabasal ke-
ratinocytes in response to wound healing. This is quite dis-
tinct from the structural role that the other epidermal ker-
atins perform in maintaining keratinocyte integrity and
begins to address the issue of why epidermal function and
homeostasis might require so many different keratin genes.
The ability to get answers to these pressing questions
has been facilitated by a mouse study that clearly defined
the structural function of the highly related keratin 14 by
gene inactivation (48). Basal cells lacking a keratin fila-
ment network because of the absence of K14 suffered ex-
tensive cytolysis resulting from the inability of these cells
to withstand mechanical trauma, resulting in an EBS-like
phenotype. This severe phenotype results in the death of
the K14 null mice, generally 
 
z
 
2 d after birth. Our goal has
been to target the expression of human K16 to the basal
 
layer of these mice as a test to determine if it can function-
ally complement the lethal phenotype of these mice. The
results of these experiments will provide in vivo informa-
tion directly comparing the functional properties of K14
and K16.
As a first step in creating the keratin replacement mice,
transgenic mice were generated that targeted the expres-
sion of K16 to the basal layer of the epidermis. As a con-
trol, mice expressing a K16-C14 chimeric protein containing
the head and rod domains of K16 and the COOH-terminal
tail domain of K14 were also generated. The K16 trans-
genic mice displayed a strong skin phenotype including
epidermal hyperproliferation and abnormalities in hair
follicle morphogenesis and hair growth. Multiple abnor-
malities in keratin filament organization and cell–cell ad-
hesion were also observed further correlating the expres-
sion of K16 with changes in keratinocyte cytoarchitecture.
The phenotype was quite distinct at the level of the organ-
ism from the previous study (82) suggesting that the con-
text of K16 expression may be very important in determin-
ing its effect. None of these phenotypic changes were
observed in the control animals allowing for implication of
the COOH-terminal tail domain of K16 as being responsi-
ble for its functional properties.
 
Materials and Methods
 
Generation and Screening of Transgenic Mice
 
All protocols involving mice were approved by the Johns Hopkins Uni-
versity Animal Care and Use Committee (Baltimore, MD). Transgenic
mice were generated by pronuclear injection using established protocols
(37). The plasmids pET-K16 (69) and pET-K16-C14 (89) were modified
to include a BamHI restriction site 5
 
9
 
 of the ATG start codon. A BamHI
digest of each plasmid generated a 1.4-kb piece of DNA encoding the
complete cDNA for each construct. This was subcloned into the BamHI
site of the modified K14 cassette expression vector (75). Clones of the cor-
rect orientation were digested with HindIII and EcoRI to generate a 6-kb
piece of DNA containing 2 kb of human K14 promoter sequence, the rab-
bit 
 
b
 
-globin intron, the cDNA of interest, and 0.6 kb of human K14 polyA
sequence. Purified DNA was microinjected into fertilized B6C3 F
 
2
 
 mouse
embryos. At 3 wk of age, potential founders were anesthetized to obtain a
small piece of tail. Genomic DNA was isolated, digested with EcoRV,
subjected to 0.8% agarose gel electrophoresis, and then transferred to a
nylon membrane (NEN Life Science Products, Boston MA). Membranes
were prehybridized for 30 min at 65
 
8
 
C in hybridization buffer (50 mM Tris,
pH 7.4, 1 M NaCl, 1% SDS, and 10% PEG 8000). Hybridization was car-
ried out overnight at 65
 
8
 
C. Blots were washed for 20 min at 65
 
8
 
C four
times with 0.1
 
3
 
 SSC, 0.5% SDS. The 1.4-kb BamHI fragments from plas-
mids pET-K16 and pET-K16-C14 were used as probes to detect the pres-
ence of the transgene by Southern blotting. These probes are specific for
transgenic animals as there is no reaction with non-transgenic mouse
DNA. All subsequent generations of mice were screened identically.
 
Determination of Transgene Protein Expression in
the Epidermis
 
To determine the amount of transgene protein that is expressed in the epi-
dermis, urea soluble proteins were isolated from dorsal skin. A 1-cm
 
2
 
piece of dorsal skin was isolated from killed animals and quick frozen in
liquid nitrogen. The frozen skin was crushed in a metal mortar and pestle
kept cold with dry ice. The fragmented pieces were homogenized in 1 ml
of buffer A (6.5 M urea, 50 mM Tris, DTT, PMSF, EDTA) for 1 min using
a PT 1200 Polytron (Kinematica AG, Littau, Switzerland) on ice. The ho-
mogenates were incubated at 37
 
8
 
C for 30 min. Supernatants were isolated
and the protein concentration was determined using the Bradford assay
(6) with reagents purchased from Bio-Rad Laboratories (Hercules, CA).
Equivalent amounts of isolated proteins (20 
 
m
 
g) were resolved via 8%
SDS-PAGE and then transferred to nitrocellulose. In addition, varying 
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amounts of human recombinant K16, K14, or K16-C14 proteins were elec-
trophoresed and transferred in tandem to determine the amount of trans-
gene expressed. Western blotting was performed using the alkaline phos-
phatase method (Bio-Rad Laboratories). Human K16 was detected using
the previously described rabbit polyclonal anti–human K16 antibody (82)
or with K8.12 (anti-K13, K15, and K16; Sigma Chemical Co., St. Louis,
MO). Mouse and human K14 and human K16-C14 were detected with the
mouse mAb LL001 (71) that recognizes an identical sequence shared be-
tween the human and mouse K14 tails. Western blots were scanned using
NIH Image 1.59 software (developed at the U.S. National Institutes of
Health and available on the world wide web via http://rsb.info.nih.gov/
nih-image/). The approximate amount of transgene protein made was cal-
culated from standard curves established with the purified recombinant
keratins. The quantitation analysis was done three times for each of the
transgenic lines.
 
Culture and Analysis of Primary Mouse Keratinocytes
 
Primary cultures of skin keratinocytes were established essentially as de-
scribed (74). Newborn mice were killed by decapitation and their limbs
were removed. The tails were used to isolate DNA for determining geno-
type. Mice were washed with 70% ethanol, 10% Proviodine, and then
70% ethanol. The skin was removed from the trunk, and washed three
times in sterile PBS–fungizone. The skin was floated (epidermis upward)
overnight in a 10-cm petri dish containing a solution of 0.25% trypsin and
40 
 
m
 
g/ml DNase in PBS at 4
 
8
 
C. The next day the epidermis was separated
from the dermis and transferred to a small petri dish containing mouse ke-
ratinocyte medium where it was gently scraped with curved forceps to iso-
late keratinocytes. The cells were pelleted and resuspended in mouse ke-
ratinocyte medium. The suspension was layered on a lympholyte M
gradient (GIBCO-BRL, Gaithersburg, MD) and centrifuged for 30 min at
500 rpm and 4
 
8
 
C. The living keratinocytes located at the interface of the
two media were isolated, centrifuged, and then resuspended. The cells
were counted and plated at a density of 2 
 
3 
 
10
 
5 
 
cells/cm
 
2
 
 on glass cover
slips. 3–4 d after plating, the primary keratinocytes were processed for im-
munofluorescence. The coverslips were washed three times in PBS and
fixed for 15 min with 100% methanol at 
 
2
 
20
 
8
 
C. After three washes with
PBS, coverslips were blocked with 5% normal goat serum in PBS. Primary
antibodies were diluted in blocking buffer and incubated for 45 min at
room temperature. FITC-conjugated goat anti–mouse and anti–rabbit,
rhodamine-conjugated goat anti–mouse and –rabbit, and FITC-conju-
gated goat anti–guinea pig secondary antibodies were used to detect
bound primary antibodies. Coverslips were mounted onto slides and ana-
lyzed via fluorescence microscopy. Primary antibodies used were mouse
mAbs LL001(anti-K14) (71) LL025 (anti-K16) (43), K8.60 (anti-K10;
Sigma Chemical Co.), K8.12 (anti-K16; Sigma Chemical Co.) and rabbit
polyclonals No. 1275 (anti-K16) (82), K6 general (anti-K6) (see Results),
K17 (anti-K17) (see Results), and No. 5054 (anti-K5 and -K6) (44).
 
Morphological Analyses
 
Mouse tissues were fixed in Bouin’s overnight at 4
 
8
 
C. The fixed tissues
were embedded in paraffin and 5-
 
m
 
m sections were stained with hematox-
ylin and eosin or immunostained using the HRP procedure as per the
manufacturer’s protocol (Kirkegaard & Perry Labs, Gaithersburg, MD).
In addition, freshly isolated dorsal and ventral skin was washed in 4
 
8
 
C
PBS and quick frozen in liquid nitrogen using OCT (Sakura Finetek, Tor-
rance, CA) as the freezing medium. 8-
 
m
 
m sections were cut, placed onto
superfrost slides (VWR Scientific Products, West Chester, PA), and im-
mediately stored at 
 
2
 
20
 
8
 
C until used. Unfixed sections were air dried for
2 min, and then hydrated in PBS. Sections were analyzed either using the
HRP protocol described above or by using indirect immunofluorescence.
For electron microscopy, ventral skin tissues were fixed in 0.1 M sodium
cacodylate and 2.5% glutaraldehyde, post-fixed in 1% osmium tetroxide,
and then embedded in LX112 epoxy-resin (Ladd Research Industries Inc.,
Burlington, VT). Ultrathin sections (50–70 nm) were placed on copper
grids, counterstained with uranyl acetate and lead citrate, and then visual-
ized using a transmission electron microscope (EM10A; Carl Zeiss Inc.,
Thornwood, NY) operated at 60 kV.
 
Immunoblot Analysis of the EGF Receptor
 
Newborn mice were killed and their skin was isolated and quick frozen in
liquid nitrogen. The skin was crushed as described above and homoge-
nized in 2 ml of lysis buffer (50 mM Tris, pH 7.4, 1% sodium deoxycho-
 
late, 1% Triton X-100, .1% SDS, 150 mM NaCl, .5 mM EDTA, 1 mM
EGTA, 10 
 
m
 
g/ml aprotinin, 10 
 
m
 
g/ml leupeptin, 1 mM PMSF, 20 
 
m
 
m
NaVO
 
4
 
, and 10 mM NaF) for 1 min using the polytron. The lysates were
centrifuged and the supernatants were isolated and the protein concentra-
tion was determined as described above. Equivalent amounts of protein
(
 
z
 
30 
 
m
 
g) were resolved via SDS-PAGE (8%) and electrophoresed onto
Nitrocellulose. The blots were incubated with an anti-EGF receptor
(EGFR)
 
1
 
 or an anti-phosphotyrosine antibody (both from Upstate Bio-
technology Inc., Lake Placid, NY) followed by incubation with HRP-con-
jugated secondary antibodies (Jackson Immunoresearch, West Grove,
PA). The signal was detected using ECL reagents from Amersham Life
Sciences (Arlington Heights, IL) and autoradiography film from Kodak
(Rochester, NY). The film was scanned using NIH image 1.59 as de-
scribed above. As a control for EGFR tyrosine phosphorylation, 200 
 
m
 
l of
10 
 
m
 
g/ml EGF (Sigma Chemical Co.) was subcutaneously injected into a
newborn mouse 10 min before the mouse was killed.
 
Results
 
Transgenic Mice Expressing Human K16 Display a
Skin Phenotype
 
As the first step in creating mice that express human K16
in the absence of K14, transgenic mice were generated to
express either the K16 or K16-C14 cDNA in the basal
layer of stratified squamous epithelia. The cDNAs were
subcloned into a modified version of the K14 expression
cassette (88, 75) as shown in Fig. 1 
 
A
 
. The two constructs
were transiently transfected in PTK2 cells and in both
cases the transgene was expressed and incorporated into
the endogenous keratin network as detected by indirect
immunofluorescence (data not shown). The K16-C14 chi-
meric cDNA encodes the head and rod of K16 fused to the
tail of K14. The two keratins share 91% amino acid se-
quence identity in their head domains and 86% identity in
their rod domains. The identity is only 38% in the tail do-
main. As previously shown (69), K16, when transiently ex-
pressed in PtK2 cells, can cause the reorganization of
the endogenous keratin filament network whereas K14
doesn’t have the same ability. When the chimera was
transfected into PtK2 cells, the results were similar to
those obtained with K14 (data not shown), suggesting that
the tail domains are responsible for the differences seen
between the two keratins. Therefore, the chimeric con-
struct was chosen as a control and was predicted to behave
in a K14-like fashion.
Four K16 transgenic founder mice and three K16-C14
chimera transgenic founder mice were obtained. Each of
the lines has been found to have a single transgene in-
sertion site. All seven founders were able to breed suc-
cessfully and each line was bred to homozygosity at the in-
sertion locus. Beginning at 
 
z
 
5 d after birth, the K16
transgenic mice develop a severe phenotype easily dis-
cernible by eye (Fig. 1 
 
B
 
). This phenotype occurs in three
of the K16 transgenic lines. Phenotypic mice show a thick-
ened and flaky skin over the entire surface of their body.
The normal emergence of hair at 
 
z
 
6–7 d after birth does
not occur. The emergence of the ears is also delayed in the
phenotypic mice. In two of the phenotypic K16 lines blis-
tering occurs in a restricted area located on the underside
of the front limbs. By 
 
z
 
3 wk, the skin of the phenotypic
mice has a more normal appearance (Fig. 1 
 
C
 
) except for
 
1. 
 
Abbreviation used in this paper
 
: EGFR, EGF receptor. 
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the obvious lack of hair. The phenotypic mice are gener-
ally smaller than non-phenotypic littermates. At 
 
z
 
5 wk,
the phenotype normalizes and hair growth begins. The re-
sultant hairs, however, are shorter and fewer in num-
ber compared with non-phenotypic littermates (data not
shown). Southern blotting of DNA from phenotypic and
non-phenotypic littermates revealed that phenotypic mice
were homozygous for the presence of the transgene while
non-phenotypic mice were either heterozygous or nega-
tive for the transgene. Mice from the three control K16-
C14 chimera lines exhibited no obvious phenotype at any
age even when homozygous for the transgene.
 
The Amount of Transgene Protein Expression in the 
Epidermis Determines the Phenotype
 
The fact that only mice homozygous for the transgene
were phenotypic suggested that the amount of transgene
being expressed was determining the phenotype. To exam-
ine this, the amount of transgene expressed in back skin
from non-transgenic, heterozygous, and homozygous lit-
termates was determined. Total urea-extractable proteins
from back skin were analyzed by SDS-PAGE and West-
ern blotting. Using known amounts of human recombinant
keratins 14 and 16, a standard curve was established using
densitometry and the amount of transgene expressed was
quantitated with respect to endogenous levels of mouse K14.
In Fig. 2 
 
A
 
 the results are shown for the phenotypic K16
transgenic line Nos. 10, 21, and 6 and in Fig. 2 
 
B
 
 are the re-
sults for the K16-C14 chimera line Nos. A2, B1, and C1.
Rabbit polyclonal antibody No. 1275, which specifically
reacts with the tail of K16 (human and mouse; see refer-
ences 18, 55) was used to detect the K16 transgene. Mouse
mAb LL001 (71), which recognizes a tail epitope that is
identical between human and mouse K14 was used to de-
tect mouse K14 and the human K16-C14 transgene. The
amount of mouse K14 in the extracts was equivalent re-
gardless of the genotype, phenotype, or transgene line
from which they were derived as determined by densitom-
etry of the K14 blot (Fig. 2 
 
A
 
). From this result, mouse
K14 was used as an internal reference to allow for quanti-
tation of transgene protein.
Extracts from control mice from either of the three K16
lines showed little or no reactivity when probed with the
1275 antibody (Fig. 2 
 
A
 
). (The faint reactivity could be due
to endogenous mouse K16 that has yet to be fully charac-
terized; see reference 55.) A strong signal was detected in
each of the three heterozygous samples. Line No. 10 ex-
presses the K16 transgene at a level of 
 
z
 
30% that of
mouse K14. Line No. 6 expresses at 
 
z
 
40%. Line No. 21
expresses an amount intermediate between the Nos. 10
and 6 lines. The levels approximately doubled when the
values for the homozygous mice were determined. K16
transgenic line No. 13, which does not display a skin phe-
notype, was found to express the transgene at approxi-
mately half the level of the No. 10 line (data not shown).
Therefore, expression of the K16 transgene to at least 60%
the level of endogenous mouse K14 is sufficient to cause
development of a skin phenotype.
The presence of minor amounts of faster migrating pro-
tein that reacted with the 1275 antibody in the homozy-
gous samples suggested that the transgene was partially
Figure 1. Generation of transgenic mice. (A) Schematic repre-
sentation of the DNA constructs used. The human K16 and K16-
C14 cDNAs were subcloned into a modified version of the K14
expression cassette (75). The cassette features 0.6 kb of human
K14 polyA sequence, the rabbit b-globin intron, and 2 kb of hu-
man K14 promoter sequence (88). Arrow, direction and initiation
site of transcription. (B) Phenotype of the K16 transgenic mice at
9 d after birth (No. 21 line). Wild-type (top) and homozygous
transgenic (bottom) littermates are pictured. The smaller pheno-
typic mouse shows an absence of fur coat and a flaky, wrinkled,
and thickened skin surface. Also, the ears have not yet com-
pletely erupted. (C) Phenotype at 3 wk (No. 10 line). Wild-type
(top) and homozygous transgenic (bottom) littermates are pic-
tured. The first hair cycle in mice is complete at z3 wk (5, 20) and
the phenotypic littermate is essentially lacking the first hair coat.
The epidermis, however, is no longer flaky and wrinkled in ap-
pearance. In contrast, the K16-C14 transgenic mice have a wild-
type appearance (data not shown). 
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degraded and that there might be other proteolytic frag-
ments not recognized by the antibody. To investigate this
possibility the samples were subjected to western analysis
using an antibody that recognizes a rod epitope present in
K16 (K8.12). No prominent bands of molecular weight
 
u
 
40 kD were observed in either the wild-type, heterozy-
gous, or homozygous K16 transgenic samples (Fig. 2 
 
C
 
). In
addition, when the same samples were subjected to SDS-
PAGE and stained with Coomassie blue the vast majority
of proteins were either full-length type I or type II keratins
(Fig. 2 
 
D
 
). There were no prominent protein bands having
a molecular weight 
 
u
 
40 kD in any of the three samples.
These data argue that there is very little stable degrada-
tion product(s) derived from the transgenic protein and
that it is the full-length K16 that leads to development of a
phenotype.
The Western blot analysis of the three chimera lines is
shown in Fig. 2 
 
B
 
. Line No. A2 did not express the trans-
gene. The other two lines did but only line No. B1 ex-
pressed at levels equivalent to the K16 phenotypic lines. In
the heterozygous state the level was 
 
z
 
50% and in the ho-
mozygous state it was 
 
z
 
70%. Mice homozygous in the No.
B1 line, however, have no obvious skin phenotype despite
expressing the transgene at a level that does cause a phe-
notype in the K16 transgenics. This supports that idea that
the K16-C14 chimera, functionally, is similar to K14.
We previously speculated that K16 protein may turn-
over faster because of its decreased ability to form stable
heterotetramers with a variety of type II keratin partners
(89). Consistent with this, the mRNA levels for the K16
transgene are higher than anticipated based on the steady-
state protein levels measured in transgenic mice (data not
shown). Moreover when the K16 and K16-C14 transgenes
are bred into the K14 null background, the amount of
transgenic protein made is increased (Paladini, R., and
P.A. Coulombe, unpublished data). Both transgenic pro-
teins bear the 
 
188
 
Pro residue that acts as a tetramer desta-
bilization determinant (89). Additional studies on these
transgenic mouse lines will provide insight into the poten-
tial posttranslational mechanisms that may regulate K16
function.
 
Phenotypic Skin Features Acanthotic Epidermis and a 
Reduction of Hair Follicles
 
To examine the histological changes in the phenotypic
mice, trunk skin from non-transgenic, heterozygous, and
homozygous 7-d-old littermates from a K16 phenotypic
line was obtained and examined by light microscopy (Fig.
3, 
 
D
 
, 
 
G
 
, and 
 
J
 
, respectively). Trunk skin was also obtained
from a 7-d-old homozygous mouse from the No. B1 chi-
mera control line (Fig. 3 
 
A
 
). The epidermis from the K16
transgenic homozygote was significantly thickened when
compared with control epidermis (compare Fig. 3, 
 
J
 
 and 
 
A
 
;
 
D 
 
and 
 
G
 
). This acanthosis involves an expansion of both
the spinous and granular layers. Many of the cells in the
spinous layer are hypertrophic (see EM data below). In
addition, the stratum corneum of the epidermis is also
thickened (hyperkeratosis). As previously mentioned, blis-
tering occurs in two of the K16 transgenic lines. The blis-
tering occurred in the suprabasal layers of the epidermis
(Fig. 3 
 
C
 
) and was extensive along the ventral surface
around the limbs of the animals. In addition, ventral skin
from phenotypic mice featured areas of parakeratosis (Fig.
3 
 
F
 
) and the presence of Munro microabcesses, a common
feature of psoriasis (11). In both the blistered and para-
keratotic epidermis, there was the presence of a large der-
mal infiltrate suggesting an inflammatory response. The
other major morphological aberration of the phenotypic
skin was a marked reduction in the number of hair folli-
cles. Many of the remaining follicles were misoriented and
did not extend deeply into the hypodermis (Fig. 3 
 
J
 
) sug-
gesting that there might a partial impairment of follicle
morphogenesis. None of these differences were seen in ei-
ther the control or heterozygote littermates or in the ho-
mozygote chimera control.
The distribution of the transgene product in these mice
was determined by performing immunohistochemical anal-
Figure 2. Determination of the level of transgene expression in the epidermis. Urea-soluble protein extracts were obtained from the
epidermides of 7-d-old control, heterozygous, and homozygous littermates from the various transgene lines. Equivalent amounts of total
urea-extractable protein (20 mg) were electrophoresed via SDS-PAGE and transferred to nitrocellulose for subsequent Western blot
analysis. (A) Western blot analysis of the K16 transgenics. The indicated amounts of purified human recombinant K14 and K16 were
used to establish a standard curve for densitometric analysis. The LL001 antibody (71) was used to detect K14 and the 1275 antibody
(82) to detect K16. (B) Western blot analysis of the K16-C14 chimera transgenics. The LL001 antibody was used to detect both mouse
K14 and the K16-C14 transgene protein. Their position of migration of each protein is indicated by the arrows on the right. Purified re-
combinant K16-C14 was used to determine the migration position of the transgene product. (C) The three No. 21 line samples were sub-
jected to Western blot analysis using the K8.12 antibody (this antibody is known to react with at least K13, K15, and K16). No bands of
molecular weight u40 kD were detected in any of the three samples. Note that a minor degradation product of the purified K16 (see D)
reacts with the antibody. The lower arrow indicates the bottom of the gel. (D) The same samples were subjected to SDS-PAGE and
stained with Coomassie blue. The are no significant protein products below the type I keratin cluster (u40 kD) and no significant differ-
ences in the total amount of keratin proteins among the three samples. 
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ysis. Control mice had no staining for the transgene in the
epidermis (Fig. 3 
 
E
 
) but occasionally displayed some faint
reactivity in the outer root sheath of hair follicles (presum-
ably, mouse K16; data not shown). The presence of the
transgene product in K16 heterozygous mice was largely
confined to the outer root sheath of hair follicles and the
basal layer of the epidermis, confirming the proper expres-
sion of the transgene in a K14-like fashion (Fig. 3 
 
H
 
; 88).
However, in the homozygous K16 transgenic skin strong
and uniform staining was present throughout all the living
layers of the epidermis (Fig. 3 
 
K
 
). The thickness of the epi-
dermis coupled with this pattern of expression was sugges-
tive of a hyperproliferative epidermis (69). The chimeric
transgene was properly expressed in the outer root sheath
of hair follicles and in the basal layer of the epidermis (Fig.
3 
 
B
 
). Since the antibody used to detect the chimeric pro-
tein recognizes the tail domain of K14, it is not possible to
distinguish the chimeric protein from the endogenous
mouse K14. The protein is present, however, as deter-
mined from the Western blot data (see Fig. 2 
 
B
 
). K16 ex-
Figure 3. Light microscopy of
the skin of control and trans-
genic mice. 5-mm paraffin sec-
tions from mice were counter-
stained with hematoxylin and
eosin (H & E) or were subjected
to immunostaining using the
HRP procedure (No. 6 line). (A,
D, G, and J) H & E–stained sec-
tion of trunk skin from 7 d mice
are shown. The epidermides of a
homozygote chimera (A), a con-
trol wild-type (D) and a K16
heterozygote (G) have a compa-
rable thickness and similar hair
follicle profiles. The epidermis
of the K16 homozygote (J) is
significantly thickened com-
pared with the others and there
is a reduction in the number of
hair follicles. Some of the folli-
cles are also incorrectly oriented
(large arrowhead). (B, E, H, and
K) Immunohistochemical detec-
tion of the transgene in skin sec-
tion from 7 d chimera homozy-
gote (B), control wild-type (E),
K16 heterozygote (H), and K16
homozygote (K). The LL001 an-
tibody was used to detect the
chimera transgene (B) and the
1275 antibody to detect the K16
transgene (E, H, K). The chi-
mera transgene expression is
correctly restricted to the outer
root sheath of hair follicles and
the basal layer of the epidermis.
Control skin (E) shows no ex-
pression of human K16 (small
asterisk, melanin granules in hair
follicle profiles) while the K16
heterozygote (H) features the
correct regulation of the trans-
gene. The K16 homozygote (K),
however, shows K16 expression
throughout all layers of the epi-
dermis. (C) H & E staining of 7 d
ventral skin from a K16 ho-
mozygote that features blister-
ing. Note the large blister (aster-
isks) that occurs within the suprabasal layers of the epidermis. (F) H & E of ventral skin from the same mouse that features
parakeratosis. The arrows indicate parakeratotic nuclei and the asterisk denotes a Munro microabcess, a common feature of psoriasis. C
and F also illustrate the presence of a large dermal infiltrate suggesting an inflammatory response. (I and L) H & E staining of 41 d dor-
sal skin from a wild-type control (I) and K16 homozygote (L), (No. 10 line). Note that at this age the epidermides of the two mice are of
comparable thickness. hf, hair follicle; sg, sebaceous gland. Arrowheads, indicate the dermal–epidermal junction. Bar, 100 mm.Paladini and Coulombe K16 Delays Skin Maturation in Transgenic Mice 1041
pression in the chimera homozygotes is restricted to the
outer root sheath (ORS) of hair follicles (data not shown).
As mentioned earlier, the phenotype of the K16 mice
begins to normalize at z5 wk after birth. That is, the mice
begin growing hair and their skin becomes increasingly
normal. Dorsal skin from a 6-wk-old non-transgenic
mouse and a homozygous K16 transgenic littermate was
processed for light microscopic analysis to confirm these
observations. The epidermides of both the control (Fig. 3
I) and the homozygote (Fig. 3 L) appeared similar with re-
spect to thickness and general morphology.
Hair Morphology of the Phenotypic Mice Is Abnormal
Dorsal hairs from 41-d-old wild-type, heterozygous, and
homozygous littermates were obtained and examined us-
ing light microscopy. Hairs from the homozygous mouse
were shorter and the distal ends were often curved and
shaped like a sickle (Fig. 4 A). Approximately 80% of the
hairs from the homozygous mouse featured this abnormal
shape. This same morphology was present in dorsal hair
examined from older (6 mo) homozygous mice although
the frequency was slightly lower (z60%). Hair from wild-
type (Fig. 4 B), and heterozygous littermates (data not
shown) were long and featured straight distal ends. Essen-
tially all of the hairs examined (98%) featured this mor-
phology. The morphology of the phenotypic hairs were
very similar to those obtained by Moore et al. (61) in their
study in which they treated newborn mice with subcutane-
ous injections of EGF. Hairs from the first coat of these
mice were reduced in diameter, shorter, and featured cur-
vature of the distal ends.
Phenotypic Epidermis Is Hyperproliferative and 
Features Aberrations in Terminal Differentiation
To examine the effects of K16 expression in the basal layer
of the epidermis on differentiation, immunohistochemistry
was performed. K14 was examined as a marker for basal
cells, K10 was used as a marker for early terminal differen-
tiation, and filaggrin was used as a marker for late differ-
entiation. Wild-type, heterozygous, and homozygous K16
transgenic littermates were examined along with homozy-
gotes from the No. B1 chimera line. Data for the heterozy-
gote K16 transgenics is not shown as the results are identi-
cal to those obtained with wild-type mice.
K14, which is expressed in the basal layer of stratified
epithelia, including the outer root sheath of hair follicles
(16) was restricted to that location in both the chimera ho-
mozygote and the control sample (Fig. 5, A and B). In con-
trast, K14 was reduced in the basal layer and extended
strongly in the suprabasal layers of the phenotypic sample
(Fig. 5 C). This pattern of K14 localization is reminiscent
of both hyperproliferative and wounded epidermis (17,
69). The expression of K10, an early marker of epidermal
keratinocyte differentiation (21, 68), was detected in the
suprabasal layers of all three samples (Fig. 5, D–F) with
the only difference being that the area of K10 expression
was thickened in the phenotypic sample due to the in-
creased number of suprabasal layers. In contrast to the
seemingly normal expression of K10, filaggrin expression
in the phenotypic sample was abnormal (Fig. 5 I). Areas of
the epidermis featured an expansion of filaggrin expres-
sion (compare to the thin layer of granular staining seen in
the homozygous chimera and control samples; Fig. 5, G
and H). In addition, there are some areas of the epidermis
where the signal appeared decreased or even absent.
These data suggest that there are deviations in the pro-
gram of terminal differentiation executed in the pheno-
typic epidermis.
To determine whether or not the epidermis of the phe-
notypic mice was hyperproliferative, mice were injected
with BrdU 2 h before they were killed. An anti-BrdU anti-
body was used to detect cells that were in S phase at the
time of sacrifice. The K16 transgenic phenotypic epidermis
had many more BrdU-positive nuclei compared with ei-
ther of the two controls (compare Fig. 6, C with A and B).
Quantitatively, the phenotypic epidermis had an approxi-
mately threefold higher mitotic index than either of the
two controls. The opposite effect was observed in the hair
follicles. The control mouse follicles had many nuclei that
were BrdU positive, whereas follicles from the K16 ho-
mozygote showed fewer positive nuclei. These data indi-
cate that the epidermis is hyperproliferative whereas the
hair follicles are hypoproliferative. At z3 wk, when the
first hair cycle is completed (5, 20) control epidermis and
hair follicles have very few BrdU-positive nuclei (Fig. 6
D). In striking contrast, there are many BrdU-positive nu-
clei in the hair follicles of the phenotypic mice (Fig. 6 E).
This data suggests that the first hair cycle in the pheno-
typic mice is dramatically delayed.
In addition to examining the mitotic activity in skin epi-
thelia, immunohistochemistry was performed to detect K6
and K17. In addition to being rapidly induced in wound
edge keratinocytes after injury to the epidermis (69), these
keratins are commonly associated with hyperproliferation
or altered differentiation in skin (79, 81, 90). K17, which is
normally expressed in the outer root sheath of the hair fol-
licle (55, 84), was detectable in all layers of the epidermis
from the K16 homozygote (Fig. 6 H). This was in stark
contrast to the normal K17 expression pattern that was ob-
served for the two controls (Fig. 6, F and G). K6 was de-
tected in the inner layer of the outer root sheath of hair
follicles in both of the controls (data not shown). K6 could
not be detected in the interfollicular epidermis. Pheno-
typic epidermis, on the other hand, featured the expres-
sion of K6 in the suprabasal layers (data not shown). The
detection of mouse K16, which is presumably also induced
Figure 4. Light microscopy of hair from control and transgenic
mice (No. 10 line). Dorsal hairs from a 41-d-old wild-type and ho-
mozygous transgenic litter mate were placed on slides, cover-
slipped, and examined using light microscopy. Control hairs (B)
are long and straight whereas the hairs from the homozygous lit-
termate (A) are shorter and feature distal ends that are curved
and sickle shaped. Bar, 100 mm.The Journal of Cell Biology, Volume 142, 1998 1042
in the hyperproliferative epidermis is not possible due to
probable cross reactivity of the 1275 antibody (see Fig. 3 K).
Basal Keratinocytes of the Phenotypic Epidermis 
Feature Multiple Cytoarchitectural Anomalies
To finely characterize the cytoarchitectural changes in the
keratinocytes of the phenotypic epidermis, ventral skin
from 6-d-old littermates was examined using transmission
electron microscopy. The control epidermis appears nor-
mal at low magnification (Fig. 7 A) All of the layers of the
epidermis, from the basal cells to the stratum corneum, are
clearly observed along with the distinctive features of each
layer.
The normal cytoarchitectural features of control basal
cells are clearly observed under higher magnification (Fig.
7 B). The basal cells have a rounded shape and are tightly
packed together as there is no observable intercellular
space. The keratin filaments are loosely packed together
and are well distributed throughout the cell. There are
multiple hemidesmosomal as well as desmosomal attach-
ments.
The large difference in thickness between control and
phenotypic epidermis is accentuated when observing phe-
notypic epidermis at the low magnification (Fig. 7 C).
Whereas the entirety of the control epidermis was visible
at this magnification (Fig. 7 A), only the basal and spinous
layers could be seen in the phenotypic epidermis. The
basal cells have an elongated shape and many gaps can be
seen between cells at both the basal and suprabasal layers.
The suprabasal cells have not reoriented their axis upon
leaving the basal layer. In addition, some suprabasal cells
featured bi-lobed nuclei, which has been observed in epi-
dermolytic hyperkeratosis (23).
The cytoarchitectural differences are much more appar-
ent when observed at the higher magnification (Fig. 7 D).
The basal cells are very elongated, as if they were being
pulled from above. Hemidesmosomal contacts appear nor-
mal although the basement membrane of the phenotypic
skin often had an undulating characteristic. The filaments
in the basal cells are packed into very electron-dense bun-
dles. As a result of this, many areas of the cytoplasm in
basal cells appear devoid of keratin filaments (Fig. 7 D, as-
terisks). The many gaps between basal cells are obvious
and the number of desmosomes appear to be reduced. An-
other distinctive feature of the phenotypic epidermis was
the presence of electron-dense inclusions in the mitochon-
dria of suprabasal cells (Fig. 7 D, inset). These were also
observed in basal cells although to a lesser extent. The
presence of these mitochondrial inclusions has been previ-
ously described (82).
Transgenic Epidermis Has Multiple Defects in
Cell–Cell Adhesion
The electron microscopy data indicated that there were
large gaps between basal cells in the epidermis. In addi-
tion, the number of desmosomes was reduced providing a
Figure 5. Immunolocalization of epi-
dermal differentiation markers in the
skin. 5-mm paraffin sections were
stained using the HRP procedure (No.
21 line). (A–C) Expression of K14 in
the chimera homozygote (A), wild-
type control (B), and K16 homozygote
(C). K14 is properly expressed in the
basal layer of the epidermis and the
outer root sheath in the two controls.
However, in the K16 homozygote (C),
the expression is now detected prima-
rily suprabasally. (D–F) Expression of
K10 in the chimera homozygote (D),
wild-type control (E), and K16 ho-
mozygote (F). K10 is properly local-
ized to the suprabasal layers of the epi-
dermis in all three samples. Expansion
of K10 expression in F is due to the in-
creased thickness of the suprabasal lay-
ers. (G–I) Filaggrin expression in the
chimera homozygote (G), wild-type
control (H), and K16 homozygote (I).
Filaggrin is expressed in the granular
layer of the epidermis in both G and H.
In the K16 homozygote (I) some areas
of agranulosis are observed (large as-
terisk) along with ectopic spinous layer
expression (arrows). Arrowheads, der-
mal–epidermal junction. hf, hair folli-
cle. Small asterisks, melanin granules in
hair follicle profiles. Bar, 100 mm.Paladini and Coulombe K16 Delays Skin Maturation in Transgenic Mice 1043
possible explanation for the decrease in cell adhesion. To
better define the changes in cell–cell adhesion, immuno-
fluorescence of frozen tissue sections was performed to ex-
amine the distribution of molecules involved in both actin
and keratin-associated adhesion complexes.
Desmoplakin was examined as a marker of desmosomal
adhesion. Detection was primarily at the surface of basal
cells in the areas of cell–cell contact (Fig. 8 A). The inten-
sity of staining increased on the surface of suprabasal cells
coinciding with the maturation of desmosomes as kerati-
nocytes differentiate (91). Cell–cell staining in the major-
ity of basal and suprabasal cells from the phenotypic epi-
dermis was reduced (Fig. 8 B) as would be expected from
the EM data.
To examine adherens junctions, an antibody was used to
detect E-cadherin. Normal epidermis featured E-cadherin
expression in all layers of the epidermis at sites of cell–cell
contact (Fig. 8 C; see reference 67). The expression of
E-cadherin was essentially absent in the basal cells of phe-
notypic epidermis (Fig. 8 D). In addition, the organization
of E-cadherin in suprabasal cells was disturbed as evi-
denced by its decreased localization at areas of cell–cell
contact. It is interesting to note that in human skin dis-
eases such as pemphigus and Darier’s the expression of
E-cadherin is markedly reduced on the surface of acan-
tholytic cells (25).
This mislocalization and absence of E-cadherin sug-
gested that other molecules involved in actin-based cell–
cell adhesion might be perturbed. To test this the localization
of b-catenin, a cytoplasmic protein involved in stabilizing
adherens junctions, was determined. b-Catenin was detected
in all layers of the epidermis at areas of cell–cell contact
from control skin (Fig. 8 E). The localization of b-catenin
in phenotypic epidermis was similar to that of E-cadherin
(Fig. 8 F), in that it was reduced in some areas of the basal
layer and was generally reduced at cell–cell interfaces in
Figure 6.  Immunolocalization
of hyperproliferation markers in
the skin. Mice were injected with
BrdU 2 h before sacrifice, and
samples from dorsal trunk skin
were paraffin-embedded, sec-
tioned, and immunostained us-
ing the HRP procedure (No. 6
line). (A–C) Trunk skin from a
7 d chimera homozygote (A), a
wild-type control (B), and a K16
homozygote (C) were stained
with an anti-BrdU antibody. The
two controls (A and B) exhibit
low labeling in the epidermis
while the hair follicles are highly
labeled. In the K16 homozygote
(C), however, the follicles show
little mitotic activity while the
epidermis is highly labeled. (D
and E) Skin from 21-d-old wild-
type control (D) and a K16 ho-
mozygote (E) stained with the
anti-BrdU antibody. Note that
the control shows very little la-
beling in both the epidermis and
the telogen stage hair follicles. In
contrast, phenotypic epidermis
still features high mitotic activity
and, in addition, the anagen
stage hair follicles are now
highly labeled. (F–H) Trunk skin
from a 7-d-old chimera homozy-
gote (F), a wild-type control (G),
and a K16 homozygote (H) were
stained with an anti-K17 anti-
body. K17 expression was re-
stricted to the outer root sheath
of hair follicles in the two con-
trols (F and G). In the K16 ho-
mozygote, however, K17 expres-
sion was detected in all layers of
the epidermis. Arrowheads, the
dermal–epidermal junction. hf,
hair follicle. Bar, 100 mm.The Journal of Cell Biology, Volume 142, 1998 1044
Figure 7. Transmission electron microscopy of phenotypic transgenic mouse epidermis (No. 6 line). Ventral skin was isolated from 6-d-old
wild-type control and K16 homozygous littermates and processed for electron microscopy. (A and C) Low magnification of epidermis.
While all layers of the epidermis can be visualized in the control (A), only the basal and spinous layers can be seen in the phenotypic epi-
dermis (C), underscoring the dramatic difference in thickness between the two. (B and D) Basal cells shown at higher magnification. (B)
Control mouse epidermis. (D) Phenotypic K16 transgenic mouse epidermis shown at the same magnification. Note the elongated shape
of the basal cells, the bundling of keratin filaments (kf), cytoplasmic areas devoid of keratin filaments (large asterisks), and the numer-Paladini and Coulombe K16 Delays Skin Maturation in Transgenic Mice 1045
all layers of the phenotypic epidermis. b-Catenin was not
detected in the nuclei of any cells in the epidermis. Similar
results were obtained for plakoglobin, a cytoplasmic mole-
cule that is part of adherens junctions and desmosomes
(19) (data not shown), with the only difference being that
it was also present in basal cells presumably because of
stabilizing interactions with components of desmosomes.
Gap junctions, a type of cell–cell adhesion complex that
metabolically couples adjacent cells, were examined in
control and phenotypic skin. Connexin 26 is normally ex-
pressed in the outer root sheath of the hair follicle but not
in the epidermis (76). However, wounding of the epider-
mis induces rapid expression of connexin 26 in suprabasal
cells near the wound edge (26). Control skin featured con-
nexin 26 expression only in the hair follicles (Fig. 8 G).
Phenotypic epidermis, however, featured the strong ex-
pression of connexin 26 in all suprabasal layers of the epi-
dermis (Fig. 8 H). This data suggests that metabolic cou-
pling between keratinocytes may also be modified in the
phenotypic epidermis.
Keratin- and actin-based cell–matrix adhesion was ex-
amined by localizing the a6 and a3 integrin subunits on
frozen skin sections. The a6 integrin subunit, which is part
of the hemidesmosome structure that attaches to keratin
filaments and the basal lamina, is restricted to the basal
and, less frequently, lateral sides of basal keratinocytes
ous gaps between cells (small asterisks). The inset shows electron dense inclusions in mitochondria (short arrows) near the nucleus of a
suprabasal cell. Large arrowheads, the basal lamina. Small arrowheads, desmosomes. ba, basal layer; sp, stratum spinosum; sg, stratum
granulosum; sc, stratum corneum; Nu, nucleus; m, mitochondria; kf, keratin filaments. Bars: (A and C) 10 mm; (B and D) 2 mm.
Figure 8. Immunolocalization
of cell adhesion molecules in
the epidermis (No. 10 line).
8-mm frozen sections of skin
from control (A, C, E, G, I,
and K) and K16 homozygote
littermates (B, D, F, H, J, and
L) were used for the localiza-
tion of cell adhesion mole-
cules by indirect immunoflu-
orescence. For the a6
integrin the HRP method
was used. Sections were
stained for Desmoplakin (A
and B), E-cadherin (C and
D),  b-catenin (E and F),
Connexin 26 (G and H), a3
integrin (I and J), and a6 in-
tegrin (K and L). Des-
moplakin staining in the
homozygote was not only
reduced at regions of cell–
cell contact but was also
prevalent in the cytoplasm
of cells (asterisks, compare B
and A). E-Cadherin was ab-
sent from the basal layer of
the homozygote (asterisks in
D) and was more disor-
ganized suprabasally com-
pared with control (C). The
results of the b-catenin stain-
ing were similar to those
obtained with desmoplakin
with the additional fact that
staining seemed reduced in
the basal layer of the ho-
mozygote (asterisks, compare
F and E). Connexin 26,
which is normally expressed
in the hair follicle (arrow) and not the epidermis (G) in control skin, was dramatically induced suprabasally in the homozygote (H). Ex-
pression of a3 integrin extended suprabasally (asterisks) in homozygous epidermis (J) as opposed to its normal basal expression in con-
trol (I). a6 integrin expression appeared comparable between homozygous (L) and control (K) epidermis with the possible exception of
increased lateral and apical staining of basal cells in the homozygote. Arrowheads, the dermal–epidermal junction. hf, hair follicle. Bars:
(A–J) 50 mm; (K and L) 50 mm.The Journal of Cell Biology, Volume 142, 1998 1046
(10). This was the localization observed in epidermis from
both the control and phenotypic animals (Fig. 8, K and L).
The a3 integrin, a key component of the bridge between
the basal lamina and actin filaments, was localized to the
basal, lateral, and apical sides of basal cells in control epi-
dermis (Fig. 8 I; see reference 10). This localization was
similar in phenotypic epidermis except for certain areas
where the expression extended suprabasally (Fig. 8 J).
Keratin Filaments Are Reorganized in Primary 
Keratinocyte Cultures from K16 Transgenic Mice
To visualize the entire keratin filament network in trans-
genic basal keratinocytes, newborn mice were killed and
isolated keratinocytes were placed in culture and pro-
cessed for immunofluorescence using a variety of antibod-
ies against different keratins. When cultured cells from
non-transgenic mice were stained to detect K16, z10% of
the cells were positive for a keratin presumed to be mouse
K16 (Fig. 9 A). When double stained with an antibody that
recognizes the endogenous K14, the two immunofluores-
cence signals were found to coalign (Fig. 9 D). All cells
from heterozygous transgenic mice were positive for the
human K16 transgene (Fig. 9 B). The transgene colocal-
ized with the endogenous keratin network as determined
by double staining with an antibody to K14 (Fig. 9 E). No
abnormalities were observed in the organization of the
keratin filaments within these cells. Other keratins ana-
lyzed including K5, K6, and K17 were found to colocalize
with the K16 transgene product (data not shown). No K10
staining was observed suggesting that the cells in culture
are basal-like (data not shown). In contrast to wild type
and heterozygotes, a subset of the homozygote kerati-
nocytes when stained for the K16 transgene featured a se-
verely disrupted keratin network in which the filaments
had relocalized in a perinuclear fashion (Fig. 9 C). This
was very reminiscent of the results obtained when K16 was
transfected into Ptk2 cells (69) and when K16 was overex-
pressed in the suprabasal cells of trangenic mice (82). The
endogenous network also featured this relocalization as
determined by staining for K14 (Fig. 9 F). The type II ker-
atins K5 and K6 also colocalized to these reorganized fila-
ments (data not shown). The fact that this relocalization is
only seen in the homozygous cells strongly argues that a
certain amount of K16 is needed with respect to the other
keratins to cause this effect.
A possible mechanism to explain the relocalization of
keratin filaments was provided by data using an antibody
to K16 that preferentially recognizes an aggregated, non-
filamentous form of the protein in cultured epithelial cells
(82). Whereas wild-type keratinocytes were negative using
this antibody (Fig. 9 G), a subset of keratinocytes from
Figure 9. Immunofluorescent analysis
of keratins in cultured primary mouse
keratinocytes (No. 10 line). Kerati-
nocytes were isolated from the epider-
mides of newborn control, K16 het-
erozygote, and K16 homozygote
littermates, cultured, and processed for
indirect, double-immunofluorescence
to analyze the keratin filament net-
works. (A–C) Keratinocytes from wild-
type control (A), heterozygote (B),
and homozygote littermates (C) were
stained with the 1275 antibody to de-
tect K16. (D–F) These same cells were
double stained with the LL001 anti-
body to detect K14. A low percentage
of wild-type cells express a keratin that
is recognized by the 1275 antibody (A).
Transgene expression in the heterozy-
gote sample was detectable in all cells
(B) and colocalized with the endoge-
nous network (E). A subset of ho-
mozygous cells (C) featured a network
in which the bulk of keratin filaments
were located near the nucleus. This in-
cluded the endogenous keratins (F).
(G–I) Wild-type (G), heterozygote
(H), and homozygote (I) keratinocytes
were stained with K8.12 antibody,
which recognizes K16 in an aggregated
form (82). A small subset of heterozy-
gote cells (H) featured punctate stain-
ing distributed throughout the cyto-
plasm. In contrast, many homozygous
cells as shown in I feature a much
higher density of punctate staining near
the nucleus. N, nucleus. Bar, 25 mm.Paladini and Coulombe K16 Delays Skin Maturation in Transgenic Mice 1047
heterozygous K16 mice showed a punctate pattern of
staining with this antibody (Fig. 9 H). These aggregates
were distributed throughout the cytoplasm and were not
preferentially located near the nucleus. The keratin fila-
ment networks of these cells appeared normal when
stained with the K14 antibody (data not shown). The per-
centage of cells with the punctate staining pattern was sig-
nificantly higher in keratinocytes derived from homozy-
gous K16 mice. In addition, a subset of cells showed a
much higher density of staining near the nucleus, with a
concomitant decrease in cytoplasmic staining (Fig. 9 I).
When these were double stained for K14, the keratin net-
work was found to be reorganized around the nucleus
(data not shown). These data suggest a relocalization
mechanism in which the first step is K16 integration
throughout the keratin filament network of the cell. At
certain areas (perhaps resulting from high K16 amounts),
the filaments form micro-aggregates. These micro-aggre-
gates may then subsequently relocalize to a perinuclear lo-
cation.
Tyrosine Phosphorylation of the EGFR in K16 
Transgenic Mice
The general morphology of the skin and the temporal na-
ture of the phenotype in the K16 transgenic mice sug-
gested that an activated EGF receptor might be involved
in generating the phenotype (see Discussion for details).
To test this, skin from newborn wild-type, heterozygous,
and homozygous littermates was obtained and the amount
and the tyrosine phosphorylation status of the receptor
was determined by Western blot analysis. EGF was subcu-
taneously injected into a control littermate to generate ty-
rosine-phosphorylated receptor to serve as a reference
(Fig. 10, control 1 EGF).
When the lysates were probed with an anti-EGFR anti-
body, approximately equivalent amounts of the z170-kD
receptor was detected in each of the samples as deter-
mined by densitometry (Fig. 10, top blot). When the con-
trol 1 EGF sample was probed with an anti-PTyr anti-
body a large band of the same apparent molecular weight
was present suggesting that the EGF receptor was highly
tyrosine phosphorylated in response to the EGF treatment
(Fig. 10, bottom blot). In contrast, control and heterozy-
gous samples featured faint reactivity of the receptor. The
homozygous sample, however, was increased twofold with
respect to the unstimulated controls as determined by den-
sitometry. It is relevant to note that the newborn skin of
the K16 transgenic homozygous mice has a normal mor-
phology with respect to control skin. However, 6-d-old
phenotypic skin did not show increased EGFR tyrosine
phosphorylation when compared with control skin (data
not shown). These data suggest that the activation of the
EGFR may be the result of K16 expression in basal cells
and that this activation may contribute to the observed
phenotype.
Discussion
The Ectopic Expression of K16 in Transgenic Mouse 
Skin Delays Skin Development
The expression of K16 protein to a certain level with re-
spect to the endogenous type I keratins in basal cells re-
sulted in multiple changes in both the development, differ-
entiation, and maturation of transgenic mouse skin. The
thickened and hyperproliferative epidermis of the pheno-
typic mice is first observed 2 d after birth (data not
shown). During the first week of postnatal growth, the
phenotypic epidermis features the aberrant expression of
multiple markers of keratinocyte localization and differen-
tiation. In addition, the hair follicles are hypoproliferative
and reduced in number compared with control animals.
Furthermore, many of the follicles are grossly disoriented
and misaligned in the hypodermis. By the end of the first
hair cycle in mice at z3 wk of age (5, 20), the phenotypic
mice are essentially hairless. However, as opposed to con-
trol mice, at day 21 the phenotypic hair follicles are now
proliferative and in the anagen phase.
Beginning at z4–5 wk after birth the phenotypic mice
begin to grow hair and their epidermis becomes thinner.
There is an apparent normalization of the skin phenotype
by this time. However, by the end of the second hair cycle
at z6 wk (5, 20), hair follicles from phenotypic mice are
still in the anagen phase as opposed to control follicles that
are in the resting phase (data not shown). Although
shorter, curved hairs are being produced, the staging of
the follicles is still aberrant. In short, the normal pattern of
embryonic and postnatal development is severely dis-
rupted in transgenic skin until z5 wk after birth. Whereas
other epidermal keratins have been ectopically expressed
in different epithelia and have impaired both the structure
and function of the targeted tissue, they had no apparent
effect on the development of the transgenic epithelia (e.g.,
references 1, 4). This is the first example of a keratin being
able to influence the morphogenesis of a complex epithe-
lium. It appears likely that the use of the K14 promoter,
which is active in the progenitor cells of the skin starting at
a very early stage of development (9), is a major factor
that contributes to the phenotype. This is in contrast to our
previous study involving increased expression of K16 un-
der the control of its own promoter (82) in which there
was no impairment of skin maturation.
Figure 10. Determination of
EGFR levels and tyrosine
phosphorylation in the K16
transgenic mice (No. 6 line).
Equivalent amounts (z30
mg) of newborn skin lysates
from control, heterozygous,
and homozygous K16 trans-
genic littermates were elec-
trophoresed via SDS-PAGE
and transferred to nitrocellulose for Western blot analysis (in du-
plicate). Top blot, the four samples were probed with an antibody
specific for the EGFR. Approximately equivalent amounts of the
receptor were present in each of the samples as determined by
densitometry. Bottom blot, the samples were probed with an anti-
body specific for phosphotyrosine. The control 1 EGF sample
featured a strong band migrating at the same apparent molecular
weight as the EGFR. The control and heterozygous samples fea-
tured faint reactivity. The homozygous sample is increased two-
fold with respect to the non-stimulated controls.The Journal of Cell Biology, Volume 142, 1998 1048
Why does the expression of wild-type keratin 16, but not
the K16-C14 chimera, in basal keratinocytes lead to a phe-
notype that is temporally regulated? Clearly, transgenic
basal keratinocytes expressing K16 are responding differ-
ently to the signals that participate in the normal develop-
ment of newborn skin. It would follow then that signal
transduction in the transgenic basal keratinocytes may de-
viate from that of the normal basal keratinocytes. These
differences could lie in the sensing, interpreting, and exe-
cution of signals or it could lie in the actual composition of
molecules involved. The exact details of these possible dif-
ferences are of great interest as they could reveal the mo-
lecular mechanisms by which keratinocytes may be able to
reprogram themselves as a function of keratin gene ex-
pression. While there may appear to be a countless num-
ber of possibilities, there is ample evidence to suggest that
the EGF receptor pathway may be involved in generating
the phenotype seen in the K16 transgenic mice.
The EGF Receptor and Skin Development
EGF was originally described as a protein that could pro-
mote proliferation and keratinization of the epidermis
while inhibiting hair growth when administered to new-
born mice (13, 46). In studies that extended these observa-
tions, the administration of EGF to newborn mice resulted
in thinner, curved hairs that grew slower (61). Further-
more, EGF treatment delayed the development of the hair
follicles during the growth of the first coat while eliciting
hyperproliferation in the epidermis (61, 62). The effects of
the treatments diminished with the increasing age of the
mice.
The EGFR is expressed in basal cells of the epidermis as
well as in the outer root sheath of hair follicles (28, 29, 32).
Expression levels in the epidermis are highest at birth and
by 4 wk have been reduced z10-fold (29). Interestingly,
basal cells overlying dermal condensates (placodes) that
mark the first stage of hair follicle development are devoid
of EGFR (65). Furthermore, EGFR staining is essentially
absent in hair follicles until z5 d after birth (32, 65).
Recently, many genetically manipulated mice have been
created that have further delineated the role of the EGFR
and its ligands in the development of skin. When TGFa,
an autocrine growth factor of epidermal cells, was overex-
pressed in basal keratinocytes and the outer root sheath of
hair follicles, the resulting mice had a scaly and thickened
epidermis that was hyperproliferative (86). Hair growth
was stunted and hair follicles were misaligned. After 5 wk,
the scaliness disappeared and hair growth was partially re-
stored. In contrast, when the TGFa gene was inactivated
by homologous recombination, the mice had wavy hair
and misaligned hair follicles (50, 51). The epidermis, how-
ever, was unaffected and increasing age reduced the sever-
ity of the hair phenotype.
Inactivation of the EGFR by homologous recombina-
tion (59, 78, 83) and the targeting of a dominant-negative
EGFR to the basal layer and outer root sheath of the epi-
dermis (63) have further emphasized the role of the recep-
tor in hair development. In each of these studies hair folli-
cles were severely misoriented and crowded and hair
growth was significantly delayed. Although the epidermis
of the dominant-negative EGFR mouse was hyperprolif-
erative (63), the epidermides from the EGFR-deficient
mice were thinner and hypoproliferative (59, 78, 83).
Collectively, these in vivo data suggest a prominent role
for the EGFR in the development of the epidermis and
the hair follicles. More specifically, they point to the
EGFR as having the role of promoting proliferation in the
epidermis while delaying the differentiation of hair folli-
cles in normal skin (32, 62). When comparing this body of
data with the phenotype of the K16 transgenic mice, the
parallels are striking. The distinguishing features of the
K16 transgenic mice including the hyperproliferative epi-
dermis, the problems of follicle orientation and morpho-
genesis, and the delay in hair growth as well as the shape
of the mature hairs strongly argue that an activation of the
EGFR pathway may be involved in generating the pheno-
type.
In newborn homozygous mice, the amount of the EGFR
in the skin was comparable to the control littermates.
However, the tyrosine phosphorylation of the receptor
was twofold that of the controls. When the same analysis
was performed on 6-d-old phenotypic mice and control lit-
termates there was no difference in either the levels or the
tyrosine phosphorylation status of the receptor. Pheno-
typic changes in the skin of homozygous mice are first no-
ticeable in 2-d-old mice while newborn skin appears
normal. Based on these data, activation of the EGFR pre-
cedes the phenotypic changes observed in the skin. The
next step will be to define the molecular mechanism by
which K16-expressing basal keratinocytes activate the
EGFR signaling pathway. This may be difficult to deter-
mine as the EGFR signaling pathway is quite complex
(34). The second messenger molecules that participate in
the pathway are also shared by other tyrosine kinase re-
ceptors and the cytokine receptors (34). Further compli-
cating matters is the presence of multiple ligands in the
skin for the EGFR (78). Whatever the possible mechanism
may be, its definition will be very interesting as the EGFR
is upregulated in wound edge keratinocytes (80) and is ex-
pected to play a prominent role in the wound healing pro-
cess (7, 8, 64, 77).
Parallels and Relevance to Wound Healing
When the skin is wounded, suprabasal keratinocytes lo-
cated at the edges of the wound undergo a process called
keratinocyte activation (14, 30). Essentially, these kerati-
nocytes do not proceed along the normal differentiation
pathway but instead are directed to participate in the re-
epithelialization of the wound. One of the earliest detect-
able events to occur is the expression of K16 protein in
these keratinocytes at 4–6 h after injury (69). In addition,
K6 and K17 are also induced while the synthesis of the dif-
ferentiation specific keratins, K1 and K10, is reduced (52,
55, 69). As the activation process occurs, the keratin fila-
ments are redistributed behind the nucleus as the cell at-
tains a migratory morphology. As this happens, multiple
changes occur, which result in the dramatic decrease in cell
adhesion among the keratinocytes. The number of desmo-
somal attachments between cells decreases (12, 69). In ad-
dition, the surface levels of E-cadherin are reduced (31)
and the expression of connexin 26 is induced (26). Further-
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suprabasal localization of the endogenous integrin sub-
units (36). Together these molecular changes result in hyper-
trophic  suprabasal keratinocytes that are loosened from
each other and are now able to migrate into the wound site.
Many of these same changes are observed in the pheno-
typic transgenic basal keratinocytes. K6 and K17 were ex-
pressed. The EM data revealed that the hypertrophic ke-
ratinocytes had fewer desmosomes, bundled filaments,
and increased space between them. E-Cadherin was essen-
tially absent in the basal layer and Connexin 26 was in-
duced suprabasally. The a3 integrin was also found in the
suprabasal layers. It is interesting to note that the expres-
sion of K16 in the basal layer, as opposed to its normal ex-
pression suprabasally, also results in keratinocytes that are
quite similar to activated suprabasal keratinocytes. This
would imply that K16 expression, along with K6 and K17
has the potential to drive a keratinocyte into the activated
state. In this case, the result is a hyperproliferative epider-
mis where the balance between proliferation and differen-
tiation has been disturbed.
The fact that K16 expression can cause a relocation of
keratin filaments from the periphery to near the nucleus of
keratinocytes provides a potential explanation for some
of the changes in cell–cell adhesion. The type II epidermal
keratins K5 and K6 both colocalize with K16 during this
process. In addition desmoplakin, a key component of des-
mosomes, also localizes to the redistributed filaments
(data not shown). K5 and K6 both have the ability to inter-
act with the tail domain of desmoplakin whereas the type I
epidermal keratins do not (41, 58). By interacting with K5
and K6 in the context of filaments, K16 may indirectly af-
fect the localization of desmoplakin and the stability of
desmosomes.
The assembly of desmosomes is dependent on the prior
formation of adherens junctions (2, 27, 47). The fact that
E-cadherin is dramatically decreased in the basal layer of
the phenotypic epidermis suggests that this may also con-
tribute to the decreased number of desmosomes. It is in-
teresting to note that E-cadherin and the EGFR colocalize
in epithelial cells (24). Furthermore, the EGFR associates
with the cadherin–catenin complex and phosphorylates
b-catenin and plakoglobin when stimulated by EGF (38).
It could be that some of the aforementioned events are re-
quired for keratinocyte activation.
Role of K16’s Tail Domain
The fact that K16 but not the K16-C14 chimeric protein
causes dramatic changes to occur in keratinocytes when
expressed at comparable levels implicates the last z105
amino acids of K16 as being the sequence responsible for
generating the phenotype. The first z60 amino acids are
located in the 2B rod domain. Of these z60 amino acids,
there are only five differences between K14 and K16.
Three of these five are conservative substitutions. The re-
maining z45 amino acids constitute the tail domain. The
sequence identity remains high along the first half of the
tail but drops dramatically along the second half of the tail
domain. There are many serines in this region of K16 and
the DGK(L/V)VS(T/E) motif, which is conserved in sev-
eral type I sequences from diverse species is absent (45
and references therein).
The exact role of the tail domains of intermediate fila-
ments is still a subject of debate. Many studies have
pointed to the tail domain as being important in regulating
the lateral aggregation of 10-nm filaments (33, 35, 40).
Other studies have implicated the tail domain as being re-
quired for the stabilization of filaments and for the proper
organization of intermediate filament networks in vivo
(49, 53, 92). In addition, the absence of the tail domain of
Xenopus vimentin resulted in the nuclear accumulation of
the protein (72). The tail domains are also substrates for
posttranslational modifications (42) and are prime candi-
dates for possible interactions with other cellular proteins.
The fact that keratin filaments of the transgenic basal
keratinocytes are thickly bundled and often show a peri-
nuclear location argue strongly that it is the tail domain of
K16 that is responsible for these changes in cellular local-
ization and lateral packing. The mechanism by which this
may occur is an active area of our investigations. As men-
tioned above, the lack of the DGK(L/V)VS(T/E) se-
quence and the presence of multiple serines may be im-
portant clues that could help in leading to a molecular
understanding of these events.
Our results strongly suggest that a certain amount of
K16 needs to be expressed to cause dramatic changes in
keratinocytes. Furthermore, the data argue that it is the
tail domain of K16 that causes these changes. The results
also suggest that the location of K16 expression in the epi-
dermis is very important in determining the subsequent
phenotypic changes since a different phenotype was ob-
served in transgenic mice overexpressing human K16 off
of its own promoter (81). This argues that the effects of
K16 on keratinocytes may be highly dependent on the spe-
cific keratin composition and the resulting filament net-
work of the keratinocyte. Finally, our results provide fur-
ther support for the idea that a primary function of K16 is
to modulate the pre-existing keratin filament network of
keratinocytes in addition to providing structural support.
The replacement mice that we are generating in which
K16 is expressed in the absence of K14 in basal kerati-
nocytes will provide answers to many of these questions.
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